Sunbeds cause cancer, and social media platforms must stop pushing them. That is the uncompromising line The Observer, the Guardian Media Group's Sunday title, has taken in a new editorial.

The intervention does not break new clinical ground. It repackages, in headline form, a position every major dermatology society has held for more than a decade: that artificial UV exposure is a confirmed human carcinogen, and that the channels marketing tanning to young audiences deserve the same regulatory attention that tobacco once commanded.

The Observer's editorial opens with a two-sentence verdict. "Sunbeds cause cancer. Social media has to stop pushing them." It is the kind of unambiguous framing dermatology advocates have spent years trying to land in mainstream coverage.

What is the cancer case against sunbeds?

Indoor tanning devices emit UVA and UVB at intensities that exceed midday equatorial sun. The International Agency for Research on Cancer moved UV-emitting tanning devices to Group 1 — its highest carcinogen category, alongside tobacco smoke, asbestos and plutonium — in 2009. The classification rested on pooled epidemiological data showing elevated melanoma risk, with the strongest signal among people whose first indoor-tanning exposure occurred before age 35.

For practising dermatologists, the clinical pattern is familiar. Sunbed-associated melanomas tend to present on intermittently exposed skin and at younger ages than typical sun-induced cases. The same exposure profile drives squamous cell carcinoma, ocular melanoma and accelerated photoageing. IARC's 2009 monograph drew on case-control studies from Europe, the United States and Australia, and subsequent meta-analyses have reinforced the association.

The regulatory record is already long. Brazil banned cosmetic sunbed use in 2009. Australia outlawed commercial solaria outright in 2015, and most Australian states tightened enforcement within the decade. Several U.S. states restrict minors' access. The United Kingdom removed the longstanding 18 per cent VAT exemption on sunbed sessions in 2023, removing a fiscal incentive from the transaction.

Why single out social media?

The Observer's editorial targets the channel rather than the device. Affiliate links, before-and-after reels and influencer partnerships have filled a vacuum left by tightening traditional advertising. In many countries, paid promotion of tanning to minors is already prohibited in broadcast media. The Observer argues the same standards should apply to algorithmic feeds.

The framing echoes long-running dermatology campaigns. The American Academy of Dermatology, the British Association of Dermatologists and the Skin Cancer Foundation have asked platforms to label, downrank or remove sunbed-promotion content. The editorial gives those calls a wider newsroom audience, and a sharper moral register.

What would meaningful platform action look like?

Three interventions recur in dermatology advocacy: age-gating of sunbed-related posts at the level already applied to alcohol and gambling, removal of paid promotion aimed at minors, and clear platform labelling of tanning content as a carcinogen-exposure product. None require new primary legislation; they sit inside existing content-moderation frameworks.

The next test is whether the major platforms respond before the northern-hemisphere summer, when indoor-tanning search volume and booking rates typically peak. Watch for any platform-policy statement or enforcement update, because that is where the editorial's pressure will register — or fail to.